During the American College of Cardiology annual meeting in March, researchers from Stanford University, Apple Inc., and other academic centers unveiled the Apple Heart Study, a first-of-its-kind large-scale study involving more than 400,000 members of the general population (iPhone and Apple Watch owners). The goal of the study was to identify users with a potentially lethal irregular heart rhythm called atrial fibrillation (AF).
Our global digital population — people around the world that are active internet users — has grown to 4.3 billion as of July 2019, representing roughly 56 percent of the global population. Of this global digital population, almost four billion are accessing the internet using mobile devices, with nontablet mobile devices contributing nearly half of web page views worldwide.
The big challenge for study sponsors is that clinical trial transparency remains a “volatile” area with continuously evolving requirements and expectations. Most life sciences companies don’t have the time, money, or resources to develop a compliance solution.
Learn how IQVIA Biotech helped a biotechnology company reach critical milestones as it prepared to launch an international Phase 3 clinical trial for its investigational ALK inhibitor in patients with non-small cell lung cancer.
A longitudinal analysis of Parkinson’s disease (PD) study characteristics provides a deeper understanding of clinical trials dynamics and demonstrates how research paradigms have been changing across the years.